Navigation Links
Perceptive Informatics Enhances Investigator Application of New RECIST Version in Imaging-Based Oncology Trials
Date:5/29/2009

BOSTON, May 29 /PRNewswire-FirstCall/ -- Perceptive Informatics, the industry's leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation (Nasdaq: PRXL), today announced the launch of a website designed to help investigators apply the new 1.1 version of RECIST (Response Evaluation Criteria In Solid Tumors) in medical imaging-based oncology trials. Perceptive Informatics, which actively participated in the RECIST Working Group, has incorporated into its RECIST website at http://www.recist.com a comparison between RECIST 1.0 and 1.1, as well as instructions on how to effectively use the new criteria.

Medical imaging experts from Perceptive Informatics will be available at Booth #1881 during the American Society of Clinical Oncology (ASCO) Annual Meeting, being held today through June 2, 2009 in Orlando, Florida, to discuss application of the new RECIST 1.1 criteria. These experts will address medical, scientific, and regulatory solutions to improve the use of medical imaging as a surrogate endpoint in oncology trials.

"Independent review using RECIST is an essential part of pivotal oncology trials," said Kenneth G. Faulkner, Ph.D., Vice President of Medical Imaging, Perceptive Informatics. "With the release of the RECIST 1.1 toolset Perceptive Informatics maintains a leading position with respect to incorporation of the RECIST criteria into Independent Review Charters for regulatory approval of oncology treatments. Perceptive remains at the forefront of incorporating the new RECIST criteria into medical imaging services to meet immediate demand from clients sponsoring oncology trials."

"Today, the majority of clinical trials evaluating cancer treatments for objective
'/>"/>

SOURCE PAREXEL International Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Perceptive Informatics Improves Clinical Trial Management With Enhanced TrialWorks(R) Solution
2. Perceptive Informatics Introduces Medical Imaging Methodology to Accelerate Development Decisions About Alzheimers Treatments
3. Perceptive Informatics Survey Results Reveal Top Barriers to Implementing Adaptive Trial Designs
4. BioInformatics, LLC New Report - Capitalizing on New Opportunities for Stem Cell Products, Now Available
5. Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy
6. Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells
7. Des Moines Register Reports SpectraScience LUMA Enhances Cervical Cancer Exams
8. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
9. Enrollment Reaches 110 Patients in Investigator Initiated, Randomized Trial of OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM)
10. Clinical Trial Participation Unaffected by Disclosure of Investigators Financial Stake, Food and Drug Law Journal Article Finds
11. PLC Medical Systems Names Lead Investigators for Pivotal Trial to Evaluate RenalGuard System(TM) and RenalGuard Therapy(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 23, 2014   Assurex Health, a personalized ... healthcare providers for behavioral health and chronic pain ... million in equity financing from new and existing ... President and Chief Executive Officer. The ... of Assurex Health,s GeneSight ®  products.  ...
(Date:12/24/2014)... BARBARA, Calif. , Dec. 23, 2014 In ... Junior Doctors, Association of Sierra Leone , ... Sierra Leone for the treatment of local health ... While a new dedicated Ebola care center was constructed ... virus, the facility is not available for local Sierra Leonean ...
(Date:12/22/2014)... 22, 2014 NxStage Medical, Inc. (NASDAQ: ... dialysis products, announced today that the U.S. Food ... One™ to perform hemodialysis overnight while the patient ... hemodialysis. NxStage,s® System One is the first and ... this indication. Home nocturnal hemodialysis ...
Breaking Medicine Technology:Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4First Ebola Treatment Unit for Local Health Workers Arrives in Sierra Leone 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 2NxStage Receives FDA Clearance for Home Nocturnal Hemodialysis 3
... New Study Results Show Antibodies Against Cancer-Causing Virus,Types ... Times Greater Than Natural,Infection Levels, CHICAGO, June 05, ... at 18 months after the first of a ... 55 vaccinated with the GlaxoSmithKline,(GSK) cervical cancer candidate ...
... Elixir,Pharmaceuticals, Inc., announced today new preclinical data,confirming ... regulating,metabolism, decreasing body weight and managing blood ... during ENDO 07, The,Endocrine Society's 89th Annual ... focused on the development of drugs to ...
Cached Medicine Technology:Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 2Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 3Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 4Cervarix, the GSK Cervical Cancer Candidate Vaccine, Provides,Sustained Immune Response in 100 Percent of Women up to 55 Years of,Age 5Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 2Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 3Elixir Pharmaceuticals Presents Additional Preclinical Data,Demonstrating the Potential of Ghrelin Antagonism to Regulate,Metabolism, Body Weight and Glycemic Control 4
(Date:12/26/2014)... 2014 Parker & Sons, Inc. ... in heating, cooling and plumbing contractor services throughout ... services in 2014 with regard to air-conditioning systems. ... is known for its incredibly hot summers. Working ... intricacies and details of a wide variety of ...
(Date:12/25/2014)... 2014 The click strand ... strength and durability. Today, the business announces a ... valid until Jan. 30, 2015. , Click strand ... hardwood. BambooFlooringChina.com is a well-known brand in the ... to find a reliable bamboo flooring supplier. , ...
(Date:12/25/2014)... 2014 Product liability lawsuits filed in ... ( http://www.consumerinjurylawyers.com/DePuy/ ) continue to move forward in federal ... issued in the U.S. District Court, Northern District of ... open conference on January 7, 2015, at the Paul ... West Palm Beach, Florida. The Conference is scheduled to ...
(Date:12/25/2014)... Recently, Dylan Queen, a famous online company supplying ... of discounted prom dresses, most of which are priced ... the company, the promotion is valid until Jan. 22, ... the UK market. , The prom dresses in this ... styles: A-line strapless, empire strapless chiffon, one shoulder, floor-length, ...
(Date:12/25/2014)... sells many bamboo products and the business is famous ... announces big discounts on its bamboo mats , which ... the world’s leader in bamboo flooring. According to the ... 2015. , The bamboo mats are made from well-treated ... the bamboo strips for the mats are boiled and ...
Breaking Medicine News(10 mins):Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 2Health News:Parker & Sons Announces Record Demand For 24 Hour Emergency Services In 2014 With Regard To Air-Conditioning Systems 3Health News:BambooFlooringChina.com: click strand woven bamboo flooring promotion valid until Jan. 30, 2015. 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 2Health News:Federal Court Overseeing DePuy ASR Hip Lawsuit Set to Convene Conference in January, Bernstein Liebhard LLP Reports 3Health News:Dylan Queen: Cheap Prom Dresses for the UK Market 2Health News:Various Styles of Bamboo Mats in Many Colors from BambooFlooringChina.com 2
... are Key Issues Facing State, LOS ANGELES, April ... first of several statewide forums on,Thursday, in which experts ... healthcare infrastructure and potential solutions., The 2008 Quality ... in healthcare workers, the wide disparities in quality of ...
... excluded or under-represented, researchers say , , TUESDAY, April ... the American clinical trial process suggests that the ... or under-represented women, older people, minorities, disabled individuals ... a big problem," said Daniel S. Goldberg, chief ...
... April 1, 2008 Breckenridge announced,today that it has ... and manufacture a generic ANDA product. Under terms of ... U.S. Food and Drug,Administration (FDA) for the product which ... U.S. sales of approximately $279 million, and,is patent protected ...
... days without food primed them for chemical onslaught and ... (HealthDay News) -- Fasting for two days before chemotherapy ... of these powerful drugs by shielding healthy cells while ... "The side effects of chemotherapy are one of the ...
... Customer relationship management company MedicareCRM(R) launches first, Web-based solution as a ... ... data, PORTLAND, Ore., April 1, 2008 ... massive report,that Medicare Advantage plans depend on to track enrollments within their,service ...
... is killed or badly injured every six seconds, experts say ... people die each year on the world,s roadways -- more ... diabetes. , In response to this growing epidemic, the United ... on road safety, to be held next year in Russia. ...
Cached Medicine News:Health News:Report Claims Clinical Trials Miss Many Populations 2Health News:Report Claims Clinical Trials Miss Many Populations 3Health News:Report Claims Clinical Trials Miss Many Populations 4Health News:Fasting Before Chemo Protects Healthy Cells 2Health News:Fasting Before Chemo Protects Healthy Cells 3Health News:Fasting Before Chemo Protects Healthy Cells 4Health News:Medicare Advantage Plans Have New, Better Way to Access CMS Data 2Health News:U.N. Seeks to Curb World's Traffic Deaths 2Health News:U.N. Seeks to Curb World's Traffic Deaths 3Health News:U.N. Seeks to Curb World's Traffic Deaths 4
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: